Breaking News

Sartorius Stedim Biotech Acquires Wave Biotech

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius Stedim Biotech GmbH (SSB) signed an agreement to acquire the Swiss-based technology company Wave Biotech AG. The two companies have been working together since 2006 on joint research projects. SSB has been exclusively marketing Wave’s product range that covers various types of single-use bioreactors and other equipment for biopharmaceutical research and manufacture.     Wave Biotech AG provides disposable bioreactors, which are an alternative to traditional reusable stainles...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters